Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | February 23, 2023 01:31pm

Gainers

  • Ambrx Biopharma (NYSE:AMAM) shares rose 30.7% to $5.96 during Thursday's regular session. The current volume of 25.6 million shares is 450.3% of Ambrx Biopharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $230.1 million.
  • Sigilon Therapeutics (NASDAQ:SGTX) shares moved upwards by 24.28% to $0.87. Trading volume for this security as of 12:30 EST is 233.6K, which is 94.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $28.2 million.
  • Eliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 22.97% to $3.56. Trading volume for Eliem Therapeutics's stock is 52.3K as of 12:30 EST. This is 419.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $94.5 million.
  • NeoGenomics (NASDAQ:NEO) stock moved upwards by 18.23% to $15.79. Trading volume for NeoGenomics's stock is 2.9 million as of 12:30 EST. This is 314.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.9 billion. The company's, Q4 earnings came out today.
  • BioVie (NASDAQ:BIVI) shares moved upwards by 17.66% to $6.66. As of 12:30 EST, this security is trading at a volume of 367.1K shares, making up 32.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $233.0 million.
  • SQZ Biotechnologies (NYSE:SQZ) shares moved upwards by 17.59% to $0.86. Trading volume for SQZ Biotechnologies's stock is 163.9K as of 12:30 EST. This is 124.4% of its average full-day volume over the last 100 days. The company's market cap stands at $25.3 million.

Losers

  • Infinity Pharmaceuticals (NASDAQ:INFI) shares fell 45.8% to $0.3 during Thursday's regular session. Trading volume for Infinity Pharmaceuticals's stock is 9.7 million as of 12:30 EST. This is 1696.1% of its average full-day volume over the last 100 days. The company's market cap stands at $26.6 million.
  • Lucira Health (NASDAQ:LHDX) shares decreased by 33.66% to $0.15. As of 12:30 EST, Lucira Health's stock is trading at a volume of 17.9 million, which is 314.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.1 million.
  • Orgenesis (NASDAQ:ORGS) shares decreased by 30.44% to $1.44. As of 12:30 EST, Orgenesis's stock is trading at a volume of 966.5K, which is 2986.9% of its average full-day volume over the last 100 days. The company's market cap stands at $36.7 million.
  • Windtree Therapeutics (NASDAQ:WINT) stock fell 29.04% to $0.18. As of 12:30 EST, this security is trading at a volume of 17.9 million shares, making up 545.9% of its average full-day volume over the last 100 days. The company's market cap stands at $7.7 million.
  • OncoSec Medical (NASDAQ:ONCS) shares fell 23.28% to $0.89. Trading volume for this security as of 12:30 EST is 453.7K, which is 47.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.6 million.
  • MEI Pharma (NASDAQ:MEIP) shares declined by 21.77% to $0.23. The current volume of 4.6 million shares is 372.2% of MEI Pharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $30.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AMAM BIVI ELYM INFI LHDX MEIP NEO ONCS ORGS SGTX SQZ WINT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist